Global Pen Needles Market is expected to reach USD 3.6 billion by 2024


Databridgemarketresearch.com presents “Global Pen Needles Market is expected to reach USD 3.6 billion by 2024”, is growing at a CAGR of 11.6% in the forecast period of 2017 to 2024.

The global pen needle market is segmented based on product type into standard and safety pen needles. The standard pen needles segment is expected to dominate the market owing to its daily usage by the diabetic patient pool. The safety pen needles are expected to grow at the highest CAGR of 15.2% is the forecast period owing to healthcare professionals striving to make insulin delivery not a regular dosage. 

The pen needles market is also segmented based on product length which varies from 4mm to 13mm in size. The pen needles segment by product length is long length, medium length and nano length needles. 

The global pen needles market is also segmented based on usability into disposable and reusable pen needles.

By application the global pen needles market is segmented into 3 indications diabetes, growth hormone deficiency and others.

Based on the drug therapy the pen needles market is segmented into insulin, glucagon-like peptide-1 and growth hormones.

Read more: http://databridgemarketresearch.com/reports/global-pen-needles-market/

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. 

 

Some of the major players in the global market include Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others.

Products or Services

The usage of pen needles in insulin delivery is increasing owing to its benefits such as more convenient as can be used while travelling, easier to use and can be handled by any one, dosage given is more accurate, pain free and better discretion.

Contact Information

Data Bridge Market Research Private Limited

Amanora Chambers , Magarpatta Road, Hadapsar
Maharashtra
411028
India
Phone : 8883872818
View website

Published in

Health

Published on

May 19, 2017